HerbParlor
Echinacea (Echinacea purpurea)Moderate evidence

Echinacea

Echinacea purpurea

Overview

At a glance

Echinacea is a group of North American coneflower species with human research most relevant to common cold and upper respiratory tract infection questions.

Key takeaway

Echinacea is not one standardized intervention: species, plant part, extraction method and preparation can materially change how the evidence should be interpreted.

Common uses studied

Common cold prevention researchCommon cold treatment researchUpper respiratory tract infection researchTraditional respiratory and other medicinal uses

Start here

What are you trying to figure out?

Pick the question closest to yours. Each card jumps to the relevant part of this profile or an existing HerbParlor tool — no sponsored rankings, no hidden ordering.

Identity

What is this herb?

Family

Asteraceae

Species

Echinacea purpurea (L.) Moench

Common names

EchinaceaPurple coneflowerAmerican coneflower

Plant parts used

Flowering aerial partsRoot

Geographic context

Echinacea species are native to North America, with Echinacea purpurea occurring naturally in eastern regions and widely cultivated elsewhere.

Identification notes

Echinacea refers to several related species. Echinacea purpurea, Echinacea angustifolia and Echinacea pallida are not automatically interchangeable, and aerial-herb and root preparations should be distinguished.

Background

Traditional context

Traditions

North American Indigenous medicinal traditions

Historical uses

Respiratory complaintsTooth painSnakebite and other traditional applications

Traditional use provides historical context but does not by itself establish modern clinical efficacy.

Preparations

Forms & preparations

Forms

Fresh flowering aerial herbExpressed juiceDried expressed juiceRoot preparationsLiquid extractsDry extractsCapsules and tabletsCombination products

Preparation methods

Expressed juice from fresh aerial herbLiquid extractionDry extraction

What changes between forms

  • Echinacea products can differ by species, plant part, extraction method and preparation.
  • Echinacea purpurea aerial-herb preparations are not equivalent to Echinacea purpurea root extracts.
  • A product containing Echinacea should not be assumed to reproduce the preparation used in a particular clinical trial.

Clinical studies have evaluated materially different Echinacea preparations, which contributes to heterogeneous results and limits generalization across products.

Research

Research Explorer

Each question summarizes what human research has examined, how it was studied, and the main limitations — not a treatment recommendation.

Can Echinacea reduce the risk of catching a common cold or upper respiratory infection?

Population

Adults and other studied populations

Intervention

Echinacea preparations

Comparator

Placebo or control

Outcomes studied

Incidence of upper respiratory infectionCommon cold occurrence

Evidence assessment

Some evidence suggests a possible preventive effect, but clinical importance remains uncertain and results vary by preparation.

Limitations

  • Preparation heterogeneity
  • Methodological heterogeneity
  • Uncertain clinical relevance

Can Echinacea shorten the duration of an established common cold?

Population

Primarily adults in clinical trials

Intervention

Echinacea preparations

Comparator

Placebo or control

Outcomes studied

Duration of upper respiratory infectionDuration of cold symptoms

Evidence assessment

Current evidence does not establish a reliable reduction in illness duration.

Limitations

  • Different products and preparations
  • Heterogeneous trial methods
  • Inconsistent results

Can Echinacea reduce common cold symptom severity?

Population

Adults with established respiratory infection

Intervention

Echinacea preparations

Comparator

Placebo or control

Outcomes studied

Cold symptom severityOverall symptom burden

Evidence assessment

Evidence is inconsistent and does not establish a dependable clinically meaningful treatment effect.

Limitations

  • Preparation differences
  • Small or heterogeneous trials
  • Variable outcome measures

Do species, plant parts and preparations change the evidence?

Population

Clinical studies of Echinacea products

Intervention

Different Echinacea species, plant parts and preparations

Comparator

Different preparations or placebo

Outcomes studied

Respiratory outcomesSafety

Evidence assessment

Yes. Product heterogeneity is a major limitation when applying research findings to commercial products.

Limitations

  • Species differences
  • Plant-part differences
  • Extraction differences
  • Formulation differences

What does the evidence show in children?

Population

Children

Intervention

Echinacea preparations

Comparator

Placebo or control

Outcomes studied

Respiratory infection incidenceSymptomsAdverse effects

Evidence assessment

Evidence in children remains limited and inconsistent.

Limitations

  • Limited number of studies
  • Inconsistent results
  • Safety considerations around allergic reactions

How established are Echinacea uses beyond common cold and respiratory questions?

Population

People using Echinacea for other health purposes

Intervention

Echinacea preparations

Comparator

Varies

Outcomes studied

Condition-specific outcomes

Evidence assessment

Evidence is insufficient to establish broad clinical benefits beyond the better-studied respiratory questions.

Limitations

  • Limited research
  • Different products
  • Insufficient evidence for many marketed uses

Latest evidence

Recently published research

Searching Europe PMC…

Looking for recent publications…

These publications are automatically discovered from Europe PMC. They have not necessarily been independently reviewed by HerbParlor and are not automatically incorporated into the evidence assessment.

Evidence

Evidence

Echinacea has a preparation-dependent human research signal around prevention of some upper respiratory infections, but evidence does not establish that Echinacea products as a class reliably prevent or treat the common cold.

Evidence tier

Moderate

Confidence

Moderate for the existence of a preparation-dependent respiratory research signal; lower for applying results from one Echinacea preparation to other commercial products.

Last evidence review

2026-09-15

Where the evidence is strongest

Possible prevention of some upper respiratory infectionsShort-term respiratory-use research

How to interpret this

The most defensible interpretation is preparation-specific rather than a blanket claim that Echinacea works or does not work. Some research suggests a possible preventive effect, while evidence for shortening or treating established colds remains uncertain or weak.

Automatic evidence update

Since the last editorial review

Checking Europe PMC…
Checking evidence

Checking for publications published since the last editorial evidence review…

This automatic update detects newly published literature; it does not replace HerbParlor's editorial evidence assessment. Review status is an automatic triage signal. Curated HerbParlor evidence is unchanged until editorial review.

Boundaries

What the evidence does NOT establish

Areas with limited evidence

  • Reliable treatment of established common colds
  • Reduction of cold duration
  • Broad immune-support claims
  • Health uses outside respiratory questions

Evidence gaps

  • Which species and preparations are most consistently effective
  • Clinically meaningful differences between preparations
  • Longer-term safety
  • How well commercial products reproduce studied interventions
  • More definitive evidence in children

Common misconceptions

  • All Echinacea supplements are equivalent.
  • Echinacea is one standardized botanical intervention.
  • Echinacea purpurea, Echinacea angustifolia and Echinacea pallida are interchangeable.
  • Root and aerial-part preparations are equivalent.
  • Any Echinacea product can be assumed to prevent colds.
  • Echinacea has been proven to shorten every common cold.
  • Immune-support marketing claims establish clinical effectiveness.
  • Evidence for one Echinacea preparation automatically applies to every Echinacea product.
  • Traditional use establishes modern clinical efficacy.
  • More Echinacea extract automatically means a stronger or better product.

Safety

Safety & interactions

General considerations

  • Short-term use of some Echinacea purpurea preparations appears reasonably well tolerated in adults, but safety depends on the species, plant part and preparation.
  • Common adverse effects include gastrointestinal symptoms such as abdominal discomfort and nausea.
  • Allergic reactions can occur and may be severe.
  • People with known allergy or hypersensitivity to Echinacea or other Asteraceae plants should avoid Echinacea preparations.
  • Long-term safety is not well established.

Contraindications

  • Known hypersensitivity or allergy to Echinacea.
  • Known hypersensitivity to other Asteraceae (Compositae) plants.
  • Some EMA assessments identify additional precautions for particular Echinacea medicinal preparations, so the specific product and formulation matter.

Pregnancy & nursing

  • Pregnancy safety is not sufficiently established for routine self-use.
  • Little is known about safety during breastfeeding.
  • Pregnant or breastfeeding people should discuss use with a qualified healthcare professional.

Medication interactions to be aware of

Evidence about clinically meaningful drug interactions is conflicting.Some Echinacea preparations have shown effects on drug-metabolizing enzymes in experimental studies, but the clinical significance is uncertain.There are theoretical reasons for caution with immunosuppressive medicines and some other medicines.People taking medicines should discuss Echinacea use with a healthcare professional rather than assuming the absence of a documented interaction means there is no risk.

Condition considerations

  • People with strong allergic tendencies or asthma may warrant additional caution because serious allergic reactions have been reported.
  • People with autoimmune disease, immunodeficiency or immunosuppression should obtain professional advice before using Echinacea because some preparations may have immunomodulatory effects.
  • Children require additional caution because evidence is limited and inconsistent and allergic skin reactions have been reported.

Reported adverse effects

  • Abdominal discomfort
  • Nausea
  • Other gastrointestinal upset
  • Skin rash
  • Allergic reactions
  • Rare severe hypersensitivity reactions including anaphylaxis have been reported

Duration

  • Evidence and regulatory assessments primarily concern short-term use of particular preparations.
  • Long-term routine use has not been adequately established.

Talk to a healthcare professional if any apply

  • Pregnancy or breastfeeding
  • Use in children
  • Known allergy to Echinacea or Asteraceae plants
  • Asthma or strong allergic tendency
  • Autoimmune disease or immunosuppression
  • Multiple prescription medicines
  • Symptoms that persist or worsen despite use for a respiratory illness
  • Possible severe allergic reaction
  • Unexplained fatigue, nausea, abdominal pain or dark urine while using an Echinacea supplement

Products

What changes between products?

Form differences

  • Echinacea products can differ by species, plant part, extraction method and preparation.
  • Echinacea purpurea aerial-herb preparations are not equivalent to Echinacea purpurea root extracts.
  • A product containing Echinacea should not be assumed to reproduce the preparation used in a particular clinical trial.

Form considerations

  • Distinguish flowering aerial herb from root preparations.
  • Distinguish expressed juice preparations from liquid or dry extracts.
  • Do not assume capsules, tablets, tinctures and juices represent the same intervention.

Plant part considerations

  • Check whether the label identifies aerial flowering parts, root, or another plant material.
  • Research and regulatory assessments may apply to a specific plant part rather than to Echinacea generally.

Extract considerations

  • Check whether the product uses fresh expressed juice, dried juice, liquid extract or dry extract.
  • Where an extract ratio or extraction solvent is supplied, record it because it can help distinguish the preparation from other products.

Standardization considerations

  • Do not assume a generic Echinacea standardization makes different species and plant parts equivalent.
  • If a product specifies marker compounds or extract characteristics, use that information to distinguish it from other preparations rather than treating the marker as proof of efficacy.

Evaluation

How to evaluate a supplement

What to check

  • Exact Echinacea species
  • Plant part used
  • Preparation or extract type
  • Amount per serving
  • Additional ingredients and combination herbs
  • Identity and contaminant testing where available
  • Batch or quality information where available

Serving considerations

  • Compare the actual serving and preparation with the intervention used in the research rather than comparing only the headline milligram amount.
  • A larger extract mass does not automatically mean a stronger or better-supported product.

Testing considerations

  • Look for identity testing and contaminant testing where available.
  • Batch-level quality information can be useful when product composition is otherwise difficult to verify.

Label transparency

  • A transparent label should identify the Echinacea species and plant part rather than only saying Echinacea.
  • The preparation or extract type should be identifiable where possible.
  • Combination products should clearly disclose the other active botanical ingredients.
  • Marketing language such as immune support should not be treated as evidence that the product reproduces a clinically studied intervention.

Categories

Related categories

Explore the HerbParlor categories this herb is grouped under.

Sources

Authoritative sources referenced

verifiedLast reviewed 2026-09-15Next review 2027-09-15

Sections reviewed

OverviewBotanical identityTraditional contextForms and preparationsResearchEvidenceSafetyProduct evaluationRelationshipsSources

Completed the Echinacea Herb Profile v1 with preparation-aware safety guidance and product-evaluation criteria grounded in authoritative and clinical sources.

This profile is provided for educational purposes only and is not medical advice. Traditional context and research summaries are distinguished from claims, and nothing here is a treatment recommendation. Always consult a qualified healthcare professional before using any herb, especially if you are pregnant, nursing, take medication, or have a medical condition.